Averin Capital Acquisition Corp. (ACAAU) Prices $250M IPO
Averin Capital Acquisition Corp. (NASDAQ:ACAAU) announced the pricing of its $250 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ACAAU”, Thursday, February 19, 2026.
The new SPAC aims to combine with a company at the intersection of technology and health that can benefit from its team’s operational expertise.
Averin Capital Acquisition Corp.’s sponsor team is led by Chairman and Chief Executive Officer David A. Berry alongside Chief Financial Officer and Secretary Alex Lau. Ulrik Schulze, Graeme Bell and Mary T. Szela will serve on its Board of Directors.
Total SPAC deal count for 2026 year-to-date is now 43. This offering is expected to close on Friday, February 20, 2026.
Deutsche Bank Securities Inc. is acting as sole book-running manager for the offering. Ellenoff Grossman & Schole LLP is serving as Issuer’s Counsel with Davis Polk & Wardwell LLP serving as Underwriter’s Counsel. MaloneBailey LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
